Skip to main content
. 2015 Jun 15;8(6):8398–8414.

Table 2.

Methods of solvent configuration in each group

Groups Methods
Group A Core 10% PLLA + 0.4 ml DI emulsification
Shell 10% PLGA
Group B Core (hydrophobic) 10% PLLA (10 mL) + 50 mg RFP + 50 mg PZA)
Shell (hydrophilic) 10% PLGA (10 mL + 0.4 ml DI + 50 mg INH + 50 mg EMBH emulsification
Group C Core (hydrophilic) 10% PLLA (10 mL) + (0.4 ml DI + 50 mg INH + 50 mg EMBH) emulsification
Shell (hydrophobic) 10% PLGA (10 mL) + (50 mg RFP + 50 mg PZA)

Note: DI, deionized water; RFP, rifampicin; PZA, pyrazinamide; INH, isoniazid; EMBH, ethambutol hydrochloride.